• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation

	Bodhi Tree Biotechnology Inc (BDTB)
	Q1-CY2026	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014	Q2-CY2014	Q1-CY2014
Balance Sheet Date			2025-Sep-30	2025-Jun-30	2025-Mar-31
Fiscal Period			Q4-FY2025	Q3-FY2025	Q2-FY2025
Total Revenue			12,000$	1$	1$			15,000$
QoQ%			1,199,900.00%	.00%
YoY%				(99.99%)
Cost Of Revenue			0$	0$	0$			0$
Gross Profit			12,000$	1$	1$			15,000$
Gross Margin			100.00%	100.00%	100.00%			100.00%
Operating Expenses			22,687$	19,976$	52,180$			5,272$	116$
Operating Income			(10,687$)	(19,975$)	(52,179$)			9,728$	(116$)
Operating Margin			(89.06%)	(1,997,500.00%)	(5,217,900.00%)			64.85%
Interest Income
Interest Expenses			0$	0$	0$
Income Before Tax			(10,687$)	(19,974$)	(52,178$)			9,728$	(116$)
Tax Expenses			0$	800$	1,250$
Net Income			(10,687$)	(20,774$)	(53,428$)			9,728$	(116$)
Profit Margin			(89.06%)	(2,077,400.00%)	(5,342,800.00%)			64.85%
TTM
Earnings to Minority
Earnings to Common Shareholders			(10,687$)	(20,774$)	(53,428$)			9,728$	(116$)
QoQ%			48.56%	61.12%				8,486.21%
YoY%				(313.55%)	(45,958.62%)
Earnings Per Share, Basic				0.00$				0.00$
Earnings Per Share, Diluted				0.00$				0.00$
Unlevered FCF Per Share, Basic				0.00$
Unlevered FCF Per Share, Diluted				0.00$
Average Shares, Basic				25,441,042				16,567,766
Average Shares, Diluted				25,441,042				16,567,766
EBIT			(10,687$)	(19,974$)	(52,178$)			9,728$	(116$)
EBITDA			(10,687$)	(19,974$)	(52,178$)			9,728$	(116$)

Copy Table ✓